▶ 調査レポート

世界の脳腫瘍治療装置市場(~2028年):指向性エネルギー治療装置、薬物・輸液・輸液治療装置、その他

• 英文タイトル:Global Brain Cancer Treatment Devices Market Insights, Forecast to 2028

Global Brain Cancer Treatment Devices Market Insights, Forecast to 2028「世界の脳腫瘍治療装置市場(~2028年):指向性エネルギー治療装置、薬物・輸液・輸液治療装置、その他」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-17060
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、114ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医療機器&消耗品
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、脳腫瘍治療装置のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
脳腫瘍治療装置のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
脳腫瘍治療装置の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
脳腫瘍治療装置のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までの脳腫瘍治療装置の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の脳腫瘍治療装置の売上および2028年までの予測に焦点を当てています。

脳腫瘍治療装置のグローバル主要企業には、Accuray Incorporated、BrainLAB AG、CarThera SAS、Elekta、GT Medical Technologies、iCAD Inc.、Integra LifeSciences、MagForce、Medtronic、Monteris Medical、Novocure GmbH、Thermo Fisher Scientific、Varian Medical Systemsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

脳腫瘍治療装置市場は、タイプとアプリケーションによって区分されます。世界の脳腫瘍治療装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
指向性エネルギー治療装置、薬物・輸液・輸液治療装置、その他

【アプリケーション別セグメント】
病院、外来手術センター、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 脳腫瘍治療装置製品概要
- タイプ別市場(指向性エネルギー治療装置、薬物・輸液・輸液治療装置、その他)
- アプリケーション別市場(病院、外来手術センター、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の脳腫瘍治療装置販売量予測2017-2028
- 世界の脳腫瘍治療装置売上予測2017-2028
- 脳腫瘍治療装置の地域別販売量
- 脳腫瘍治療装置の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別脳腫瘍治療装置販売量
- 主要メーカー別脳腫瘍治療装置売上
- 主要メーカー別脳腫瘍治療装置価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(指向性エネルギー治療装置、薬物・輸液・輸液治療装置、その他)
- 脳腫瘍治療装置のタイプ別販売量
- 脳腫瘍治療装置のタイプ別売上
- 脳腫瘍治療装置のタイプ別価格
・アプリケーション別市場規模(病院、外来手術センター、その他)
- 脳腫瘍治療装置のアプリケーション別販売量
- 脳腫瘍治療装置のアプリケーション別売上
- 脳腫瘍治療装置のアプリケーション別価格
・北米市場
- 北米の脳腫瘍治療装置市場規模(タイプ別、アプリケーション別)
- 主要国別の脳腫瘍治療装置市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの脳腫瘍治療装置市場規模(タイプ別、アプリケーション別)
- 主要国別の脳腫瘍治療装置市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の脳腫瘍治療装置市場規模(タイプ別、アプリケーション別)
- 主要国別の脳腫瘍治療装置市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の脳腫瘍治療装置市場規模(タイプ別、アプリケーション別)
- 主要国別の脳腫瘍治療装置市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの脳腫瘍治療装置市場規模(タイプ別、アプリケーション別)
- 主要国別の脳腫瘍治療装置市場規模(トルコ、サウジアラビア)
・企業情報
Accuray Incorporated、BrainLAB AG、CarThera SAS、Elekta、GT Medical Technologies、iCAD Inc.、Integra LifeSciences、MagForce、Medtronic、Monteris Medical、Novocure GmbH、Thermo Fisher Scientific、Varian Medical Systems
・産業チェーン及び販売チャネル分析
- 脳腫瘍治療装置の産業チェーン分析
- 脳腫瘍治療装置の原材料
- 脳腫瘍治療装置の生産プロセス
- 脳腫瘍治療装置の販売及びマーケティング
- 脳腫瘍治療装置の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 脳腫瘍治療装置の産業動向
- 脳腫瘍治療装置のマーケットドライバー
- 脳腫瘍治療装置の課題
- 脳腫瘍治療装置の阻害要因
・主な調査結果

Find out more about the different brain tumor types and treatments, including surgery, radiation therapy and chemotherapy.Treatment options include those described below, such as surgery, radiation therapy, chemotherapy, and targeted therapy. For a low-grade brain tumor, surgery may be the only treatment needed, especially if all of the tumor can be removed.The outlook for a malignant brain tumour depends on things like where it is in the brain, its size, and what grade it is. It can sometimes be cured if caught early on, but a brain tumour often comes back and sometimes it isn’t possible to remove it.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Brain Cancer Treatment Devices estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Brain Cancer Treatment Devices is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Brain Cancer Treatment Devices is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Brain Cancer Treatment Devices is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Brain Cancer Treatment Devices include Accuray Incorporated, BrainLAB AG, CarThera SAS, Elekta, GT Medical Technologies, iCAD Inc., Integra LifeSciences, MagForce and Medtronic, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Brain Cancer Treatment Devices companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Brain Cancer Treatment Devices market. Further, it explains the major drivers and regional dynamics of the global Brain Cancer Treatment Devices market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Accuray Incorporated
BrainLAB AG
CarThera SAS
Elekta
GT Medical Technologies
iCAD Inc.
Integra LifeSciences
MagForce
Medtronic
Monteris Medical
Novocure GmbH
Thermo Fisher Scientific
Varian Medical Systems
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Brain Cancer Treatment Devices Segment by Type
Directional Energy Therapy Equipment
Drug/Fluid Delivery and Infusion Therapy Devices
Others
`
Brain Cancer Treatment Devices Segment by Application
Hospital
Outpatient Surgery Center
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Brain Cancer Treatment Devices market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Brain Cancer Treatment Devices market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Brain Cancer Treatment Devices, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Brain Cancer Treatment Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Brain Cancer Treatment Devices revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Brain Cancer Treatment Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Brain Cancer Treatment Devices revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Accuray Incorporated, BrainLAB AG, CarThera SAS, Elekta, GT Medical Technologies, iCAD Inc., Integra LifeSciences, MagForce and Medtronic, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Brain Cancer Treatment Devices in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Cancer Treatment Devices companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Brain Cancer Treatment Devices revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Cancer Treatment Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Directional Energy Therapy Equipment
1.2.3 Drug/Fluid Delivery and Infusion Therapy Devices
1.2.4 Others
1.2.6 `
1.3 Market by Application
1.3.1 Global Brain Cancer Treatment Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Outpatient Surgery Center
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Brain Cancer Treatment Devices Market Perspective (2017-2028)
2.2 Brain Cancer Treatment Devices Growth Trends by Region
2.2.1 Brain Cancer Treatment Devices Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Brain Cancer Treatment Devices Historic Market Size by Region (2017-2022)
2.2.3 Brain Cancer Treatment Devices Forecasted Market Size by Region (2023-2028)
2.3 Brain Cancer Treatment Devices Market Dynamics
2.3.1 Brain Cancer Treatment Devices Industry Trends
2.3.2 Brain Cancer Treatment Devices Market Drivers
2.3.3 Brain Cancer Treatment Devices Market Challenges
2.3.4 Brain Cancer Treatment Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Cancer Treatment Devices Players by Revenue
3.1.1 Global Top Brain Cancer Treatment Devices Players by Revenue (2017-2022)
3.1.2 Global Brain Cancer Treatment Devices Revenue Market Share by Players (2017-2022)
3.2 Global Brain Cancer Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brain Cancer Treatment Devices Revenue
3.4 Global Brain Cancer Treatment Devices Market Concentration Ratio
3.4.1 Global Brain Cancer Treatment Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Cancer Treatment Devices Revenue in 2021
3.5 Brain Cancer Treatment Devices Key Players Head office and Area Served
3.6 Key Players Brain Cancer Treatment Devices Product Solution and Service
3.7 Date of Enter into Brain Cancer Treatment Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Cancer Treatment Devices Breakdown Data by Type
4.1 Global Brain Cancer Treatment Devices Historic Market Size by Type (2017-2022)
4.2 Global Brain Cancer Treatment Devices Forecasted Market Size by Type (2023-2028)
5 Brain Cancer Treatment Devices Breakdown Data by Application
5.1 Global Brain Cancer Treatment Devices Historic Market Size by Application (2017-2022)
5.2 Global Brain Cancer Treatment Devices Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Brain Cancer Treatment Devices Market Size (2017-2028)
6.2 North America Brain Cancer Treatment Devices Market Size by Type
6.2.1 North America Brain Cancer Treatment Devices Market Size by Type (2017-2022)
6.2.2 North America Brain Cancer Treatment Devices Market Size by Type (2023-2028)
6.2.3 North America Brain Cancer Treatment Devices Market Share by Type (2017-2028)
6.3 North America Brain Cancer Treatment Devices Market Size by Application
6.3.1 North America Brain Cancer Treatment Devices Market Size by Application (2017-2022)
6.3.2 North America Brain Cancer Treatment Devices Market Size by Application (2023-2028)
6.3.3 North America Brain Cancer Treatment Devices Market Share by Application (2017-2028)
6.4 North America Brain Cancer Treatment Devices Market Size by Country
6.4.1 North America Brain Cancer Treatment Devices Market Size by Country (2017-2022)
6.4.2 North America Brain Cancer Treatment Devices Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Brain Cancer Treatment Devices Market Size (2017-2028)
7.2 Europe Brain Cancer Treatment Devices Market Size by Type
7.2.1 Europe Brain Cancer Treatment Devices Market Size by Type (2017-2022)
7.2.2 Europe Brain Cancer Treatment Devices Market Size by Type (2023-2028)
7.2.3 Europe Brain Cancer Treatment Devices Market Share by Type (2017-2028)
7.3 Europe Brain Cancer Treatment Devices Market Size by Application
7.3.1 Europe Brain Cancer Treatment Devices Market Size by Application (2017-2022)
7.3.2 Europe Brain Cancer Treatment Devices Market Size by Application (2023-2028)
7.3.3 Europe Brain Cancer Treatment Devices Market Share by Application (2017-2028)
7.4 Europe Brain Cancer Treatment Devices Market Size by Country
7.4.1 Europe Brain Cancer Treatment Devices Market Size by Country (2017-2022)
7.4.2 Europe Brain Cancer Treatment Devices Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Cancer Treatment Devices Market Size (2017-2028)
8.2 Asia-Pacific Brain Cancer Treatment Devices Market Size by Type
8.2.1 Asia-Pacific Brain Cancer Treatment Devices Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Brain Cancer Treatment Devices Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Brain Cancer Treatment Devices Market Share by Type (2017-2028)
8.3 Asia-Pacific Brain Cancer Treatment Devices Market Size by Application
8.3.1 Asia-Pacific Brain Cancer Treatment Devices Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Brain Cancer Treatment Devices Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Brain Cancer Treatment Devices Market Share by Application (2017-2028)
8.4 Asia-Pacific Brain Cancer Treatment Devices Market Size by Region
8.4.1 Asia-Pacific Brain Cancer Treatment Devices Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Brain Cancer Treatment Devices Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Brain Cancer Treatment Devices Market Size (2017-2028)
9.2 Latin America Brain Cancer Treatment Devices Market Size by Type
9.2.1 Latin America Brain Cancer Treatment Devices Market Size by Type (2017-2022)
9.2.2 Latin America Brain Cancer Treatment Devices Market Size by Type (2023-2028)
9.2.3 Latin America Brain Cancer Treatment Devices Market Share by Type (2017-2028)
9.3 Latin America Brain Cancer Treatment Devices Market Size by Application
9.3.1 Latin America Brain Cancer Treatment Devices Market Size by Application (2017-2022)
9.3.2 Latin America Brain Cancer Treatment Devices Market Size by Application (2023-2028)
9.3.3 Latin America Brain Cancer Treatment Devices Market Share by Application (2017-2028)
9.4 Latin America Brain Cancer Treatment Devices Market Size by Country
9.4.1 Latin America Brain Cancer Treatment Devices Market Size by Country (2017-2022)
9.4.2 Latin America Brain Cancer Treatment Devices Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Cancer Treatment Devices Market Size (2017-2028)
10.2 Middle East & Africa Brain Cancer Treatment Devices Market Size by Type
10.2.1 Middle East & Africa Brain Cancer Treatment Devices Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Brain Cancer Treatment Devices Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Brain Cancer Treatment Devices Market Share by Type (2017-2028)
10.3 Middle East & Africa Brain Cancer Treatment Devices Market Size by Application
10.3.1 Middle East & Africa Brain Cancer Treatment Devices Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Brain Cancer Treatment Devices Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Brain Cancer Treatment Devices Market Share by Application (2017-2028)
10.4 Middle East & Africa Brain Cancer Treatment Devices Market Size by Country
10.4.1 Middle East & Africa Brain Cancer Treatment Devices Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Brain Cancer Treatment Devices Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Accuray Incorporated
11.1.1 Accuray Incorporated Company Details
11.1.2 Accuray Incorporated Business Overview
11.1.3 Accuray Incorporated Brain Cancer Treatment Devices Introduction
11.1.4 Accuray Incorporated Revenue in Brain Cancer Treatment Devices Business (2017-2022)
11.1.5 Accuray Incorporated Recent Developments
11.2 BrainLAB AG
11.2.1 BrainLAB AG Company Details
11.2.2 BrainLAB AG Business Overview
11.2.3 BrainLAB AG Brain Cancer Treatment Devices Introduction
11.2.4 BrainLAB AG Revenue in Brain Cancer Treatment Devices Business (2017-2022)
11.2.5 BrainLAB AG Recent Developments
11.3 CarThera SAS
11.3.1 CarThera SAS Company Details
11.3.2 CarThera SAS Business Overview
11.3.3 CarThera SAS Brain Cancer Treatment Devices Introduction
11.3.4 CarThera SAS Revenue in Brain Cancer Treatment Devices Business (2017-2022)
11.3.5 CarThera SAS Recent Developments
11.4 Elekta
11.4.1 Elekta Company Details
11.4.2 Elekta Business Overview
11.4.3 Elekta Brain Cancer Treatment Devices Introduction
11.4.4 Elekta Revenue in Brain Cancer Treatment Devices Business (2017-2022)
11.4.5 Elekta Recent Developments
11.5 GT Medical Technologies
11.5.1 GT Medical Technologies Company Details
11.5.2 GT Medical Technologies Business Overview
11.5.3 GT Medical Technologies Brain Cancer Treatment Devices Introduction
11.5.4 GT Medical Technologies Revenue in Brain Cancer Treatment Devices Business (2017-2022)
11.5.5 GT Medical Technologies Recent Developments
11.6 iCAD Inc.
11.6.1 iCAD Inc. Company Details
11.6.2 iCAD Inc. Business Overview
11.6.3 iCAD Inc. Brain Cancer Treatment Devices Introduction
11.6.4 iCAD Inc. Revenue in Brain Cancer Treatment Devices Business (2017-2022)
11.6.5 iCAD Inc. Recent Developments
11.7 Integra LifeSciences
11.7.1 Integra LifeSciences Company Details
11.7.2 Integra LifeSciences Business Overview
11.7.3 Integra LifeSciences Brain Cancer Treatment Devices Introduction
11.7.4 Integra LifeSciences Revenue in Brain Cancer Treatment Devices Business (2017-2022)
11.7.5 Integra LifeSciences Recent Developments
11.8 MagForce
11.8.1 MagForce Company Details
11.8.2 MagForce Business Overview
11.8.3 MagForce Brain Cancer Treatment Devices Introduction
11.8.4 MagForce Revenue in Brain Cancer Treatment Devices Business (2017-2022)
11.8.5 MagForce Recent Developments
11.9 Medtronic
11.9.1 Medtronic Company Details
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Brain Cancer Treatment Devices Introduction
11.9.4 Medtronic Revenue in Brain Cancer Treatment Devices Business (2017-2022)
11.9.5 Medtronic Recent Developments
11.10 Monteris Medical
11.10.1 Monteris Medical Company Details
11.10.2 Monteris Medical Business Overview
11.10.3 Monteris Medical Brain Cancer Treatment Devices Introduction
11.10.4 Monteris Medical Revenue in Brain Cancer Treatment Devices Business (2017-2022)
11.10.5 Monteris Medical Recent Developments
11.11 Novocure GmbH
11.11.1 Novocure GmbH Company Details
11.11.2 Novocure GmbH Business Overview
11.11.3 Novocure GmbH Brain Cancer Treatment Devices Introduction
11.11.4 Novocure GmbH Revenue in Brain Cancer Treatment Devices Business (2017-2022)
11.11.5 Novocure GmbH Recent Developments
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Details
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Brain Cancer Treatment Devices Introduction
11.12.4 Thermo Fisher Scientific Revenue in Brain Cancer Treatment Devices Business (2017-2022)
11.12.5 Thermo Fisher Scientific Recent Developments
11.13 Varian Medical Systems
11.13.1 Varian Medical Systems Company Details
11.13.2 Varian Medical Systems Business Overview
11.13.3 Varian Medical Systems Brain Cancer Treatment Devices Introduction
11.13.4 Varian Medical Systems Revenue in Brain Cancer Treatment Devices Business (2017-2022)
11.13.5 Varian Medical Systems Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer